For example, in the case of prostate cancer, SOX2 levels rise in concert with increases in Gleason score [51], whereas in other cancers, such as SHH medulloblastoma, it is unclear whether SOX2 levels rise during tumor progression. Here, SOX2 is linked to cancer.